Advertisement
Screener

G1 THERAPEUTICS, INC. Earnings Per Share (Diluted)

G1 THERAPEUTICS, INC. Earnings Per Share (Diluted)

G1 THERAPEUTICS, INC. reported Earnings Per Share (Diluted) of -$0.10 per share for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareDiluted · last filed 2024-08-08

  • G1 THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2024-06-30 was -$0.10, a 171.43% decline year-over-year.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2024-03-31 was -$0.20.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2023-12-31 was -$0.21.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.35.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for fiscal 2023 was -$0.93.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for fiscal 2022 was -$3.38.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for fiscal 2021 was -$3.54.
  • G1 THERAPEUTICS, INC. earnings per share, diluted for fiscal 2020 was -$2.62.
Period endEarnings Per Share, Diluted 3 monthEarnings Per Share, Diluted 6 monthEarnings Per Share, Diluted 9 monthEarnings Per Share, Diluted 12 month
2024-06-30-$0.10
10-Q · filed 2024-08-08
-$0.30
10-Q · filed 2024-08-08
-$0.51
derived: net income ÷ weighted average shares · filed 2024-08-08
-$0.86
derived: net income ÷ weighted average shares · filed 2024-08-08
2024-03-31-$0.20
10-Q · filed 2024-05-01
-$0.41
derived: net income ÷ weighted average shares · filed 2024-08-08
-$0.76
derived: net income ÷ weighted average shares · filed 2024-08-08
-$0.56
derived: net income ÷ weighted average shares · filed 2024-08-08
2023-12-31-$0.21
derived: net income ÷ weighted average shares · filed 2024-02-28
-$0.56
derived: net income ÷ weighted average shares · filed 2024-02-28
-$0.37
derived: net income ÷ weighted average shares · filed 2024-08-08
-$0.93
10-K · filed 2024-02-28
2023-09-30-$0.35
10-Q · filed 2023-11-01
-$0.17
derived: net income ÷ weighted average shares · filed 2024-08-08
-$0.72
10-Q · filed 2023-11-01
-$1.34
derived: net income ÷ weighted average shares · filed 2024-08-08
2023-06-30$0.14
10-Q · filed 2024-08-08
-$0.37
10-Q · filed 2024-08-08
-$0.99
derived: net income ÷ weighted average shares · filed 2024-08-08
-$1.54
derived: net income ÷ weighted average shares · filed 2024-08-08
2023-03-31-$0.53
10-Q · filed 2024-05-01
-$1.25
derived: net income ÷ weighted average shares · filed 2024-08-08
-$1.84
derived: net income ÷ weighted average shares · filed 2024-08-08
-$2.75
derived: net income ÷ weighted average shares · filed 2024-08-08
2022-12-31-$0.73
10-K · filed 2023-03-01
-$1.32
derived: net income ÷ weighted average shares · filed 2023-11-01
-$2.24
derived: net income ÷ weighted average shares · filed 2023-11-01
-$3.38
10-K · filed 2024-02-28
2022-09-30-$0.59
10-Q · filed 2023-11-01
-$1.51
derived: net income ÷ weighted average shares · filed 2023-11-01
-$2.67
10-Q · filed 2023-11-01
-$3.61
derived: net income ÷ weighted average shares · filed 2023-11-01
2022-06-30-$0.92
10-Q · filed 2023-08-02
-$2.08
10-Q · filed 2023-08-02
-$3.02
derived: net income ÷ weighted average shares · filed 2023-11-01
-$4.02
derived: net income ÷ weighted average shares · filed 2023-11-01
2022-03-31-$1.15
10-Q · filed 2023-05-03
-$2.09
derived: net income ÷ weighted average shares · filed 2023-11-01
-$3.10
derived: net income ÷ weighted average shares · filed 2023-11-01
-$4.03
derived: net income ÷ weighted average shares · filed 2023-11-01
2021-12-31-$0.94
10-K · filed 2023-03-01
-$1.94
derived: net income ÷ weighted average shares · filed 2023-03-01
-$2.88
derived: net income ÷ weighted average shares · filed 2023-03-01
-$3.54
10-K · filed 2024-02-28
2021-09-30-$1.00
10-K · filed 2023-03-01
-$1.94
derived: net income ÷ weighted average shares · filed 2023-03-01
-$2.60
10-Q · filed 2022-11-02
2021-06-30-$0.94
10-K · filed 2023-03-01
-$1.59
10-Q · filed 2022-08-03
2021-03-31-$0.65
10-K · filed 2023-03-01
2020-12-31-$2.62
10-K · filed 2023-03-01